Reveal Pharmaceuticals
PrivateLast Round
Grant
Jun 5, 2023
Total Funding Raised
$7.99M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Reveal Pharmaceuticals is a biotechnology company that develops gadolinium-free MRI contrast agents to provide safer medical imaging and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reveal Pharmaceuticals Comparables
Compare Reveal Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoxort | 86% | |
| GE HealthCare Technologies Inc. | 80% | |
| Phos4nova B.V. | 78% |
Reveal Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 5, 2023 | ||||
| Grant | Jun 9, 2022 | ||||
| Grant | Sep 3, 2019 | ||||
| Grant | Oct 1, 2018 | ||||
| Grant | Sep 3, 2018 |
Reveal Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| MassVentures | Grant |
| Massachusetts Life Sciences Center | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 36% MoM.
- Jul 24, 2026
Monthly visitors increased 38% MoM.
Reveal Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Reveal Pharmaceuticals's valuation, stock price, and market status.
Is Reveal Pharmaceuticals a public or private company?
Reveal Pharmaceuticals is a private company.
What is the current stock price of Reveal Pharmaceuticals?
Reveal Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Reveal Pharmaceuticals worth (valuation)?
Valuation information for Reveal Pharmaceuticals is not publicly available.
Can I buy Reveal Pharmaceuticals stock?
Reveal Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Reveal Pharmaceuticals's last funding round?
Reveal Pharmaceuticals's most recent funding round was Grant on June 5, 2023.
Who are the main investors in Reveal Pharmaceuticals?
Key investors in Reveal Pharmaceuticals include National Cancer Institute, NIH RADx, MassVentures, Massachusetts Life Sciences Center.
Will Reveal Pharmaceuticals IPO soon?
No public IPO plans have been announced for Reveal Pharmaceuticals.
How can I track Reveal Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Reveal Pharmaceuticals's secondary market activity and sign up for updates.